|
07/15/2008
|
Sigma-Aldrich is proud to announce that Aldrichimica Acta has again been ranked #1 by Impact Factor, out of 56 similar journals in the field of Organic Chemistry.
|
|
05/07/2008
|
Sigma-Aldrich(TM) and the second phase of The RNAi Consortium (TRC2) have commenced functional validation of the Consortium's collection of approximately 160,000 previously-cloned lentiviral-based shRNA vector constructs.
|
|
02/14/2008
|
Sigma-Aldrich today announced an exclusive partnership with Atlas Antibodies to distribute Prestige Antibodies(TM) -- developed by the Human Proteome Resource -- to the proteomics and cell biology research communities.
|
|
12/31/2007
|
Sigma-Aldrich(TM) will release its 2008-2009 Sigma Life Science Catalog (http://www.sigma.com/sigmacatalog), a comprehensive source guide for the life science researcher, in January 2008.
|
|
06/19/2007
|
Sigma-Aldrich (Nasdaq: SIAL) is pleased to launch ChemDose(TM), a novel compound handling technology designed to enable easy delivery of reagents and catalysts in tablet form.
|
|
06/12/2007
|
Sigma-Aldrich (Nasdaq: SIAL) is pleased to announce it has signed a licensing agreement with Epigentek Group, Inc. to further develop and commercialize technologies for Epigenetics research.
|
|
06/07/2007
|
Sigma-Aldrich (Nasdaq: SIAL) proudly announces the launch of the PhosDecor(TM) Fluorescent Phosphoprotein In-Gel Detection Kit, a highly sensitive and selective tool for the identification of phosphorylated proteins.
|
|
06/04/2007
|
Sigma-Aldrich announces the launch of the AQUA (Absolute Quantitation) Peptide Partnership Program, where Proteomic researchers ordering custom AQUA Peptides from Sigma-Aldrich will be invited to join the world's first AQUA Peptide Partnership Program.
|
|
05/21/2007
|
SAFC, a member of the Sigma-Aldrich Group (Nasdaq: SIAL), announced today that its Supply Solutions business segment has received a license for Beckman Coulter's (NYSE: BEC) fast deprotection chemistry.
|
|
05/08/2007
|
Sigma-Aldrich Corporation announced today that it has acquired Molecular Medicine BioServices Inc. (MMB), a biopharmaceutical contract manufacturing organization (CMO) located in Carlsbad, California.
|
|
04/26/2007
|
Sigma-Aldrich, a leading $1.8 billion Life Science and High Technology company, is pleased to introduce Your Favorite Gene(TM), a new comprehensive, Web-based search tool that matches genes of interest against thousands of Sigma-Aldrich research products.
|
|
04/25/2007
|
SAFC, a member of the Sigma-Aldrich Group (Nasdaq: SIAL), has announced the construction completion of two major new protein API facilities at its St. Louis, Missouri manufacturing campus.
|
|
04/19/2007
|
Sigma-Aldrich (Nasdaq: SIAL), a leading $1.8 billion Life Science and High Technology company, is pleased to announce it has concluded an agreement with ChiroSolve Inc., a San Jose, CA based company, to market and exclusively distribute ChiroSolv Kits.
|
|
04/12/2007
|
Sigma-Aldrich, announced today that more than 1,100 of its bioactive small molecules have been uploaded to the National Institutes of Health's (NIH) PubChem, a publicly accessible database of chemical structures and biological assay data.
|
|
03/21/2007
|
SAFC, a member of the Sigma-Aldrich Group, continues its appointment as a high-potency active pharmaceutical ingredient (API) manufacturing partner for Vion Pharmaceuticals' Cloretazine(R) anti-cancer drug.
|
|
03/15/2007
|
Sigma-Aldrich is pleased to announce the launch of the Panorama(TM) Antibody Microarray XPRESS Profiler725 ( http://sigma.com/expressionprofile ), a high-throughput tool for multiplex protein expression profiling of serum, cell or tissue extracts.
|
|
03/13/2007
|
Sigma-Aldrich announced today that it has established a new $200 million multi-currency senior revolving credit facility in Europe. The new $200 million credit facility will mature on March 13, 2014.
|
|
03/08/2007
|
Sigma-Aldrich, (Nasdaq: SIAL), a leading $1.8 billion Life Science and High Technology company, is pleased to announce it has been named a recipient of Merck & Co., Inc.'s prestigious 2006 Sector Operational Award.
|
|
03/06/2007
|
Sigma-Aldrich announced today the release of its first two MISSION siRNA Druggable Genome Libraries for Human and Rat (http://sigma.com/missionsirna) to address the needs of researchers to quickly and cost-effectively screen for gene function.
|
|
03/01/2007
|
Sigma, a division of Sigma-Aldrich (Nasdaq: SIAL), a leading $1.8 billion Life Science and High Technology company, is pleased to introduce the QuantiGene(R) 2.0 RNA Quantification System (http://sigma.com/quantigene).
|
|
02/27/2007
|
Supelco, a division of Sigma-Aldrich Corporation (Nasdaq: SIAL), announced today that it has entered a global distribution agreement with Fondazione Salvatore Maugeri (FSM) to distribute the Radiello(R) passive/diffusive air samplers.
|
|
02/15/2007
|
SAFC, a member of the Sigma-Aldrich Group (Nasdaq: SIAL), announced today that it has completed the initial phase of a two-stage expansion at its SAFC Pharmorphix(TM) research facility in Cambridge, U.K., for its SAFC Pharma business.
|
|
02/12/2007
|
Sigma-Aldrich Corporation announced today that it has acquired all of the outstanding shares of Epichem Group Limited of Bromborough, United Kingdom, to expand its SAFC Hitech business offering. The purchase price of $60 million was paid in cash.
|
|
02/01/2007
|
Sigma-Aldrich has enhanced its Bioactive Nutrient Explorer. This Internet-based tool has been specifically designed to help nutrition and animal scientists, medical researchers, biologists, and analytical chemists.
|
|
01/30/2007
|
Sigma-Aldrich is pleased to announce it has launched Protease Finder, a novel Internet-based program expected to accelerate customers' success by providing a targeted proteolytic enzyme search capability unavailable on the Web today.
|
|
01/25/2007
|
Sigma-Aldrich (Nasdaq: SIAL), a leading $1.7 billion Life Science Company and member of The RNAi Consortium (TRC), proudly welcomes the Vanderbilt-Ingram Cancer Center and the University of Michigan to the RNAi Partnership Program.
|
|
01/16/2007
|
SAFC announced today that its SAFC Pharma business segment has been appointed by Affichem, a French biotechnology company, to provide chemical development services relating to Dendrogenine A, a potential cancer treatment.
|
|
01/03/2007
|
Sigma-Aldrich (Nasdaq: SIAL), a leading $1.7 billion Life Science and High Technology company, announced that it has granted Pfizer a worldwide non-exclusive research license to utilize DNA-directed RNAi (ddRNAi) technology.
|
